OrbiMed
Fund Type
Venture Fund
Founding Year
1989
About
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Stages
Seed, Series A, Series B, Series C, Series D
Investments
562
Geography
New York
Exits
212
Sectors
BioTechMedical DevicePharmaceuticalsHealthcareHR TechFemTechHealth & WellnessLife ScienceArtificial Intelligence & Machine Learning (AI/ML)SoftwareFood and BeverageMobile
Portfolio Companies
Aspen NeuroscienceCarrot FertilitySionna TherapeuticsGentiBioXtalPiReCode TherapeuticsScribe TherapeuticsEntosQ32 BioACELYRINCyrus BiotechnologyiECUREGennao BioEnliven TherapeuticsArriVent BiopharmaCrown BiosciencePionyr ImmunotherapeuticsOdyssey TherapeuticsAdicet BioBinx HealthTurnstone BiologicsElectra Therapeutics